Sumanont Sermsak, Boonard Manusak, Peradhammanon Ekachot, Arirachakaran Alisara, Suwankomonkul Pattanapong, Oungbumrungpan Worawit, Kongtharvonskul Jatupon
Department of Orthopedic, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Orthopedics Department, Phrachomklao Hospital, Pedchburi, Thailand.
Eur J Orthop Surg Traumatol. 2018 Apr;28(3):397-407. doi: 10.1007/s00590-017-2056-z. Epub 2017 Oct 12.
Subacromial impingement syndrome (SIS) is one of the most frequent pathologies of the shoulder, which may cause serious restriction of daily activities and lifestyle changes. Corticosteroid injection (CI) into the subacromial space is a palliative treatment option. Currently, there have been no studies that compare between the different volumes of CI injection. We have conducted a systematic review and meta-analysis to answer our specific study questions: Are high volume (< 5 ml) better than low volume (≥ 5 ml) of CI injection with respect to pain reduction? This systematic review was conducted according to the preferred reporting items for systematic reviews and meta-analyses guidelines. Relevant studies were identified from Medline and Scopus from inception to May 11, 2017 that reported American shoulder and elbow surgeons (ASES) function score, pain visual analog score (VAS), and postoperative complications of either group. Fifteen studies were included for the analysis of high volume (more than or equal 5 ml), and 5 studies were included for analysis of low volume (less than 5 ml). Overall, there were 1101 patients (732 in the high-volume group and 369 in the low-volume group). A pooling of mean VAS and ASES function score was (N = 557) 2.02 (95% CI 1.52, 2.53), (N = 190) 82.59 (95% CI 76.92, 88.27) in high-volume group and (N = 179) 2.60 (95% CI 1.94, 3.26), (N = 95) 84.65 (95% CI 81.64, 86.82) in low-volume group, respectively. The unstandardized mean difference of ASES and VAS of high volume was - 0.58 (95% confidence interval (CI): - 1.38, 0.22) and - 2.06 (95% CI - 8.35, 4.23) scores lower than low-volume CI in SIS patients, but without statistical significance. A total of 11 studies in the high-volume group and 4 studies in the low-volume group reported adverse effects. The total complication rate per patient was 6.2% (2.3, 10.1%) in the high-volume group and 11.7% (0.3, 12%) in the low-volume group (p = 0.091). No significant differences were noted for complications. In subacromial impingement syndrome, the corticosteroid injection had acceptable pain and functional outcomes. Higher volume had a lower ASES, VAS, and risk of having complication when compared to lower volume. However, there are no statistically significant differences between groups. Larger, randomized noninferiority or equivalent trial studies are needed to confirm these findings as the current literature is still insufficient. Level of evidence I.
肩峰下撞击综合征(SIS)是肩部最常见的病症之一,可能会导致日常活动严重受限和生活方式改变。向肩峰下间隙注射皮质类固醇(CI)是一种姑息治疗选择。目前,尚无研究比较不同注射量的CI。我们进行了一项系统评价和荟萃分析,以回答我们的具体研究问题:就减轻疼痛而言,高剂量(<5毫升)CI注射是否优于低剂量(≥5毫升)?本系统评价是根据系统评价和荟萃分析的首选报告项目指南进行的。从Medline和Scopus数据库中检索了从创建到2017年5月11日期间报告美国肩肘外科医师学会(ASES)功能评分、疼痛视觉模拟评分(VAS)以及两组术后并发症的相关研究。纳入15项研究用于高剂量(大于或等于5毫升)分析,5项研究用于低剂量(小于5毫升)分析。总体而言,共有1101例患者(高剂量组732例,低剂量组369例)。高剂量组平均VAS和ASES功能评分合并值分别为(N = 557)2.02(95%CI 1.52,2.53)、(N = 190)82.59(95%CI 76.92,88.27),低剂量组分别为(N = 179)2.60(95%CI 1.94,3.26)、(N = 95)84.65(95%CI 81.64,8,6.82)。SIS患者中,高剂量组ASES和VAS的未标准化平均差值分别比低剂量CI低 -0.58(95%置信区间(CI):-1.38,0.22)和 -2.06(95%CI -8.35,4.23)分,但无统计学意义。高剂量组有11项研究、低剂量组有4项研究报告了不良反应。高剂量组每位患者的总并发症发生率为6.2%(2.3,10.1%),低剂量组为11.7%(0.3,12%)(p = 0.091)。并发症方面未观察到显著差异。在肩峰下撞击综合征中,皮质类固醇注射具有可接受的疼痛和功能结局。与低剂量相比,高剂量组的ASES、VAS更低,并发症风险也更低。然而,两组之间无统计学显著差异。由于目前的文献仍然不足,需要更大规模的随机非劣效性或等效性试验研究来证实这些发现。证据级别I。